Loading company…
VedaBio develops a CRISPR-based molecular detection platform.
VedaBio is developing CRISPR Cascade for multiplexed molecular detection without target amplification. The company aims to apply the platform in diagnostics, medicines and research. Founded in 2021, it is based in California, US. It raised USD 40 million in venture funding led by OMX Ventures in October 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in